Delivery Order SPE2DB22D3301-SPE2DB24FZ0EK
Award Date
7/9/24
Potential Completion Date
7/10/24
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of GADAVIST 1 MMOL/ML BULK VIAL 30ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $1,711.35 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract has a completion date of July 2, 2024 and was awarded on July 1, 2024. There was no set-aside designation used for this award. Amerisourcebergen holds a larger...
Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, has been awarded a $2,920.36 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical. This contract is for the provision of GADAVIST 7.5 MMOL/7.5 ML VIAL 7.5ML, a specialty pharmaceutical product, to support military treatment programs and facilities. The contract has a completion date of February 6, 2024. Amerisourcebergen Drug...
Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, was awarded a $1,140.90 firm fixed price delivery order from the Defense Logistics Agency (DLA) to provide GADAVIST 1 MMOL/ML BULK VIAL 30ML. This delivery order is part of an indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product Gadavist (10 mL vial). The $5,505.64 firm-fixed-price contract has an ultimate completion date of August 24, 2022. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle for delivering a range of pharmaceutical and...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $5,749.28 firm fixed-price delivery order is for the supply of Gadavist 10 MMOL/10 ML Vial 10ML, with a final completion date of August 8, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a wide range of medical products and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for $1,217.80 to supply Gadavist 10 mmol/10 mL vials. The award is not set aside and has a completion date of September 6, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including to military treatment facilities, veterans' hospitals, and other federal healthcare...
The Defense Logistics Agency awarded a $1,711.35 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 30ml GADAVIST 1 MMOL/ML bulk vial pharmaceutical products. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, to provide a comprehensive range of pharmaceutical products and medical supplies to the DLA Troop Support Medical...
The U.S. Defense Logistics Agency (DLA) awarded a $1,180.34 firm fixed-price delivery order to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide Gadavist 1 mmol/ml bulk vials. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for the company to supply a comprehensive range of pharmaceutical products and medical supplies to support...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $1,216.74, is a firm fixed-price delivery order for the supply of GADAVIST 7.5 MMOL/7.5 ML SYR 7.5ML, a medical product. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,052.45 firm fixed-price delivery order is for the medical product "GADAVIST 10 MMOL/10 ML VIAL 10ML" and has a period of performance through November 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...